Kartesia, the European specialist provider of capital solutions for small and mid-sized companies, has provided financing to Gilde Healthcare, a specialist healthcare investor, for its acquisition of Acti-Med, one of the leading manufacturers of medical technology, specialising in medical cannulas and cannula systems with production facilities in Germany and Poland.
Kartesia has provided a unitranche loan from KSO I, the proceeds of which will be used to finance the acquisition, with further funds committed and funded over the course of the next few years to support Gilde Healthcare in pursuing growth plans for Acti-Med. Gilde Healthcare will collaborate with Acti-Med to further strengthen and expand its product portfolio, as well as further expand its manufacturing and design capacity. The deal team consisted of Laurent Bouvier, Thomas Pöhler, Niclas Paulin and Kristina Ivanova.
Thomas Pöhler, Director, Kartesia, said, “This further investment from our inaugural KSO fund demonstrates the important role alternative lenders like Kartesia play in proving financing solutions across Europe. Acti-Med is indicative of the businesses we look to support – highly specialised, leaders in their field with excellent prospects for future development and growth. We look forward to working with Gilde Healthcare and Acti-Med on the execution of their plans.”
Rafael Natanek, Partner at Gilde Healthcare, added: “We value the support and flexibility in financing solutions Kartesia has offered in completing the acquisition of Acti-Med. We are excited to be investing in the company’s continued growth and look forward to supporting the management as we consider additional options, such as strategic acquisitions.”
Kartesia announced the final closing of its inaugural €1bn senior debt fund, KSO I, in March 2021. The Senior Opportunities strategy provides senior financing solutions to European small and medium-sized companies with strong credit profiles, leveraging Kartesia’s expertise, proprietary network and successful track record in European credit markets.